Orthopedic Biomaterials Market Report Suite | Australia | 2020-2026 | Medsuite

Orthopedic Biomaterials Market Report Suite | Australia | 2020-2026 | Medsuite


The full report suite on the Australian market for orthopedic biomaterials includes bone graft substitutes, which are represented by allografts, demineralized bone matrix (DBM) allografts and synthetics. This report also includes orthopedic growth factors and hyaluronic acid (HA) viscosupplementation.

  • Year: 2020
  • Scope: 2016-2026
  • Region: Australia
  • Published Date: 07/02/2020
  • Pages: 288
  • Type: MedSuite

With some exceptions, tissue supply for allografts and DBM allografts is constrained by the number of available donors. Furthermore, allografts are primarily sold by bone banks in Australia, which is attributed to a relatively high barrier to entry to the market for international companies. As the population ages, there will be a lower supply of eligible bone graft donors. Bones from the elderly are more likely to be weaker or suffer from degenerative diseases, which would be unsuitable for donation.

While this report suite contains all data, each of the markets are also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need. You can view all these included reports and segmentation here:

  • Procedure Numbers for Orthobiologics – MedPro: Using a number of databases, internal and external, we’re able to provide you with the total volume of orthopedic biomaterials procedures being performed for each of the markets mentioned in this suite of reports.
  • Orthopedic Bone Graft Substitute Makrket – MedCore: Bone is a biologically active tissue and will regenerate whenever possible; however, there are instances where the damage is significant enough to warrant a scaffold to help rejoin the fissure or cavity. Bone grafting is a surgical procedure in which damaged bone is replaced with autograft tissue, allograft tissue or a bone graft substitute, which can be either synthetic or metal.
  • Hyaluronic Acid Viscosupplementation Market – MedCore: Hyaluronic acids (HAs) are naturally occurring biopolymer fluids found in the joints that help cushion them from wear. Sufferers of osteoarthritis are deficient in these fluids. One of the treatment options for these patients is HA viscosupplement injections. Viscosupplements are injectable products that come in three varieties of injection regimens. The market consisted of single-injection, three-injection and five-injection. These products are classified as medical devices in the majority of circumstances. In China, however, HA products are classified as drugs.
  • Orthopedic Growth Factor Market – MedCore: Growth factors are a group of small, soluble proteins that bind onto cell surface receptors, triggering a series of signals that regulate the body’s ability to grow, renew and heal. Due to the regenerative properties of growth factors, they have been exploited for bone healing in orthopedic applications.

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2026, and Historical Data to 2016
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Procedure Volumes
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios for Top Competitors
  • Related Press Releases from Top Competitors

Orthobiologics Market Share Insights

In 2019, the leading competitor in the Australian orthopedic biomaterials market was Medtronic. The company has established this role through strong performance of its growth factor product line, INFUSE®, which first entered the market in 2006. Medtronic also held a notable position in the DBM allograft and synthetic markets.

For a Full Table of Contents From Any of the Country Reports in this Global Series, please Contact iData

All Companies Analyzed in this Study

  • Alphatec
  • Anika Therapeutics
  • Arthrex
  • Australian Biotechnologies
  • Australian Tissue Donation Network
  • B. Braun
  • Barwon Health Bone Bank
  • Baxter
  • Biocomposites
  • Bioventus
  • Cerapedics
  • Corin
  • DePuy Synthes
  • Donor Tissue Bank of Victoria
  • Finceramica
  • Globus Medical
  • Hunter New England and Local Health District
  • Hunter New England Bone Bank
  • Institute of Medical & Veterinary Science
  • Joy Surgical
  • JRI Orthopaedics
  • Kasios
  • LifeHealthcare
  • LMT Surgical
  • Medacta
  • Medical + Optical
  • Medtronic
  • New South Wales Bone Bank
  • NovaBone
  • NuVasive
  • Orthotech
  • OsteoMed
  • Perth Bone and Tissue Bank
  • Precision Surgical
  • Prism Surgical
  • Pureplay Orthopaedics
  • Queensland Tissue Bank
  • Rachel Forster Bone Bank
  • Sanofi
  • Signature Spine and Joint
  • SIGNUS Medical
  • Smith & Nephew
  • South Eastern Sydney Local Health District
  • Stryker
  • Tecres
  • The Queensland Bone Bank
  • Wright Medical
  • Zimmer Biomet

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers